---
figid: PMC6053314__bloodbook-2017-556-g005
figlink: /pmc/articles/PMC6053314/figure/F5/
number: F5
caption: NF-κB Activation in primary CNS lymphoma. NF-κB transcriptional activation
  is regulated by multiple signals in PCNSL, including the MYD88/IRAK complex and
  the BCR complex consisting of CD79A and B. Activation of IRAK kinases via the oncogenic
  mutation of MYD88 at L265P impacts ∼55% of PCNSL cases. MYD88 is an adapter protein
  that mediates Toll-like receptor and interleukin-1 receptor signaling. Chronic active
  signaling via the BCR involving BTK likely cooperates with the MYD88/IRAK pathway
  in NF-κB activation. Other prosurvival signals include PIM kinases, the PI3K/mTOR,
  and JAK/STAT pathways. NF-κB target genes such as IRF-4, BCL-2, cyclin D2, RGS-13,
  and XBP-1 likely potentiate survival, proliferation, and invasion. IL, interleukin;
  MALT1, mucosa-associated lymphoid tissue; mTOR, mammalian target of rapamycin; PI3-K,
  phosphoinositide 3-kinase; PKC-β, protein kinase C beta; RGS, regulator of G-protein
  signaling; XBP-1, X-box binding protein-1.
pmcid: PMC6053314
papertitle: Biology of CNS lymphoma and the potential of novel agents.
reftext: James L. Rubenstein. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):556-564.
pmc_ranked_result_index: '105430'
pathway_score: 0.9599907
filename: bloodbook-2017-556-g005.jpg
figtitle: NFKB Activation in primary CNS lymphoma
year: '2017'
organisms:
- Homo sapiens
ndex: 1c3d188f-dec9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6053314__bloodbook-2017-556-g005.html
  '@type': Dataset
  description: NF-κB Activation in primary CNS lymphoma. NF-κB transcriptional activation
    is regulated by multiple signals in PCNSL, including the MYD88/IRAK complex and
    the BCR complex consisting of CD79A and B. Activation of IRAK kinases via the
    oncogenic mutation of MYD88 at L265P impacts ∼55% of PCNSL cases. MYD88 is an
    adapter protein that mediates Toll-like receptor and interleukin-1 receptor signaling.
    Chronic active signaling via the BCR involving BTK likely cooperates with the
    MYD88/IRAK pathway in NF-κB activation. Other prosurvival signals include PIM
    kinases, the PI3K/mTOR, and JAK/STAT pathways. NF-κB target genes such as IRF-4,
    BCL-2, cyclin D2, RGS-13, and XBP-1 likely potentiate survival, proliferation,
    and invasion. IL, interleukin; MALT1, mucosa-associated lymphoid tissue; mTOR,
    mammalian target of rapamycin; PI3-K, phosphoinositide 3-kinase; PKC-β, protein
    kinase C beta; RGS, regulator of G-protein signaling; XBP-1, X-box binding protein-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCR5
  - BCL2
  - BCL2A1
  - CXCL13
  - MALT1
  - MTOR
  - CD79B
  - JAK2
  - BCL10
  - XBP1
  - JAK1
  - IRAK1
  - BCR
  - BTK
  - IL4
  - PIM1
  - PIM2
  - PRKCB
  - STAT6
  - STAT3
  - SYK
  - TRAF6
  - IL10
  - PIK3CB
  - PIK3R6
  - IRAK4
  - IRF4
  - CCND2
  - CARD11
  - CD79A
  - NFKB1
  - PIK3CA
  - PIK3R3
  - MYD88
  - PIK3CD
  - PIK3CG
  - RGS13
  - PIK3R5
  - PIK3R4
  - Cancer
genes:
- word: CXCR5
  symbol: CXCR5
  source: hgnc_symbol
  hgnc_symbol: CXCR5
  entrez: '643'
- word: BCL2,
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: BCL2A1,
  symbol: BCL2A1
  source: hgnc_symbol
  hgnc_symbol: BCL2A1
  entrez: '597'
- word: CXCL13
  symbol: CXCL13
  source: hgnc_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CD79B
  symbol: CD79B
  source: hgnc_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: BCL-10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: XBP-1
  symbol: XBP1
  source: hgnc_symbol
  hgnc_symbol: XBP1
  entrez: '7494'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IRAK-1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: IL-4/IL-10
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: PIM1
  symbol: PIM1
  source: hgnc_symbol
  hgnc_symbol: PIM1
  entrez: '5292'
- word: PIM2
  symbol: PIM2
  source: hgnc_symbol
  hgnc_symbol: PIM2
  entrez: '11040'
- word: PKC-B
  symbol: PKCB
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: STAT3/6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT3/6
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: TRAF-6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: IL-4/IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IRAK-4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRF-4,
  symbol: IRF4
  source: hgnc_symbol
  hgnc_symbol: IRF4
  entrez: '3662'
- word: IRF-4,RGS13,CyclinD2,BCL2,BCL2A1,XBP-1
  symbol: Cyclin-D2
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CARD11
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: CD79A
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IRF-4,RGS13,CyclinD2,BCL2,BCL2A1,XBP-1
  symbol: RGS13
  source: hgnc_symbol
  hgnc_symbol: RGS13
  entrez: '6003'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6053314__F5
redirect_from: /figures/PMC6053314__F5
figtype: Figure
---
